Flerie AB (publ) (FLERIE.ST)
Flerie AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Stockholm, AB, SE. The stock last traded at $17.20, down 1.15% on the session, giving a market capitalisation of $1.49B. Its beta of -0.44 implies it has historically moved less than the broad market.
Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.
Flerie AB (publ) is most often compared with the following Healthcare names: